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Background: Anti Retroviral Therapy (ART) is the cornerstone for comprehensive health sector response to Human
Immunodeficiency Virus (HIV) treatment, care and support. Adherence of at least 95% is needed to keep HIV under
control, as per World Health Organization (WHO) guidelines. This study was aimed at identifying the overall
adherence level of, and barriers and facilitators to adherence for patients taking ART in different clinics in all five
development regions of Nepal.
Methods: A descriptive cross-sectional study was conducted among ART clients receiving free ART from Government of
Nepal ART clinics. A total of 435 clients taking ART from twelve ART clinics in different regions of Nepal, aged fifteen years
and above were interviewed on one-and-one basis using questionnaires developed in reference to Adult AIDS Clinical
Trial Group (AACTG) toolkit among them data from 404 were analyzed after cleaning. Data was entered and analyzed
using Statistical Package for Social Sciences (SPSS) software where the P value of < 0.05 was accepted as being
statistically significant.
Results: The overall adherence in the last month (missed less than three pills total) was 94.8% (383 out of 404). The
main barrier to ART adherence was the fear of side effects (among 61.9% of the non adherent population) which
included dizziness (18.1%) and headaches (15.4%). The standard wristwatch (39%) was found to be the most useful
aid in enabling timely consumption of medication. Educational status (P = 0.018), drug using habits (P = 0.039) and
the conducive environment at ART clinics (P = 0.004) were significantly associated with ART adherence.
Conclusion: Improving better adherence may require a more holistic approach to treatment regimen and adapting it
to patient daily routines. This study identifies issues such as pill count for assessing adherence, better access to health
care facilities by clients, better access to medication, as well as improved nutritional support issues for better
adherence by the population in the future.
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Approximately 34 million people worldwide are cur-
rently living with Human Immunodeficiency Virus (HIV)
and nearly 30 million people have died of Acquired Im-
mune Deficiency Syndrome (AIDS)-related causes since
the beginning of the epidemic [1]. Most People Living
with HIV (PLHIV) or at risk for HIV do not have access
to prevention, care, and treatment, and there is still no
cure [2]. The progress of Anti Retro Viral (ARV) drugs
has renovated HIV and AIDS to that of a chronic manage-
able disease. Earlier studies have reported improved qual-
ity of life of PLHIV on ART, reduced progression of the
disease and declining mortality from the pandemic [3].
Nepal, with estimated 54,626 PLHIV is presently fa-
cing a concentrated epidemic with the adult (15–49 yo)
HIV prevalence rate of 0.33% (2010). With support from
the Global Fund to fight against AIDS, Tuberculosis and
Malaria (GFATM), a national program providing free ac-
cess to ART began in Nepal during 2004, and by the end
of July 2010, a total of 6,754 clients had enrolled into
treatment at the twenty five ART and ten sub ART
clinics in Nepal [3]. In 2005, Nepal adopted a National
ART Guideline, but even now, only 21% of those esti-
mated to be in need are actually able to access ART ser-
vices. There are estimated 17,000 people in need of ART
in Nepal [4].
The standard ART service consists of the use of at
least three ARV drugs to maximally suppress the HIV
and to stop the disease progression [5]. An ART adher-
ent person is one who does not miss more than three
doses of ART treatment in a given time period [5].
Literature provides strong evidence that a non-adherent
HIV patient on ART triple therapy is 3.87 times more
likely to die than an adherent patient on the same therapy
[6]. Additionally, benefits associated with ART compared
with other less active forms of treatment are considerably
reduced when the patient is non-adherent with the treat-
ment [7]. Further, the risk of dying for an adherent patient
on ART is nine times lower in comparison with the other
types of treatment, this risk is only three times lower when
the patient is non-adherent [7]. Adherence to ART is
therefore clearly a critical factor in prolonging lives of
PLHIV. The best response to ART is seen when adherence
is 100%. Levels of adherence below 95% have been associ-
ated with poor suppression of HIV viral load and a lower
increase in CD4 count [8]. Evidence suggests that greater
than 95% adherence may be necessary to adequately sup-
press viral replication, produce a durable response and
halt disease progression [9]. Previous studies [6,7] by dif-
ferent groups suggest that adherence to ART regimen
among PLHIV is far from being satisfactory and better
monitoring is required to achieve this. Both the PLHIV
and the service providers have various reasons for ART
regimen not being followed as prescribed.Despite the availability of free ART services in Nepal,
deaths due to AIDS still exist, and the prevalence of HIV
among key affected populations still remains quite high
[4]. In order for ART to work, clients have to stringently
stick to the regime of medications. Failure to do so can
undermine the effectiveness of the treatment and viral
load can increase faster than it would have, otherwise.
Furthermore, there is evidence from the field suggests
that the second line ART regimen is being followed by
some clients without completing the standard ART regi-
men. This brings in new queries regarding the efficacy of
the ART on clients. Therefore, this is another issue that
needs to be closely assessed as the ART adherence by
clients is scrutinized. As the topographical difficulties,
socio economic barriers coupled with the vertical nature
of the current service delivery system, it is important to
know the rate of adherence on ART by the clients.
There is currently no country level ART adherence data.
This study was thus initiated with the aim of a) identify-
ing ways to best ensure that PLHIV follow ART regimen,
b) measure the level of ART adherence at selected ART
clinics, and c) identify gaps in ART adherence monitor-
ing and support and to provide recommendations to
scale up ART adherence. The expected results were to
provide evidence what to address and/or promote to
scale up the adherence and to contribute towards de-
signing better directed and more culturally sensitive in-
terventions to optimize the adherence rate to ART in
Nepal. This would then serve as a resource for further
research for developing new protocols for improvement
in future.Methods
Study design and site
A descriptive cross-sectional study was conducted at
twelve ART sites (Figure 1) among then available twenty
five ART sites of the Nepal, covering all the five develop-
ment regions of the country (Table 1). A total of 435
clients on ART as per proportional sampling were ran-
domly interviewed from July to November 2010.Study population
Clients on ART for at least six months above the age of
fifteen years and who agreed to give informed consent
were included in the study. For the participants of the
study under the age of eighteen, informed consent was
received from the parent or guardian. Participants who
were too ill to be interviewed were excluded.
WHO sample size determination for health studies
formula was used to determine the sample size of the
study [10].The total sample size was determined to be
435 by taking 95% confidence interval, 84.0% level of
ART adherence [11],5% margin of error, design effect of
Figure 1 Study sites (map of Nepal adapted with permission from http://ncthakur.itgo.com/map04.htm).
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views, and 80% power.
At 95% Confidence Interval (CI), with the allowable
error of 5%. The sample size was calculated Sample Size
nð Þ ¼ Z2p 1−pð Þa2
p = 84.0%
α = Allowable error = 0.05
n = (1.96)²x0.84x0.16/ (0.05)²=206.5≃ 207.
A design effect of 2 was added to minimize the clus-
tering effect as stated in other surveys sample size after
including design effect-207x2=414. Anticipating chance
of receiving incomplete interviews we then increased the
final sample size by 5% which is now 435.Table 1 Breakdown of selected ART sites by development reg
Far Western Mid Western
ART centers in the country 5 3
ART centers selected 3 1The multistage sampling technique was used to select
the study participants. In the first stage, 12 ART clinics
were randomly selected by the lottery method from 25
ART centers in different regions of Nepal (Table 1). In
the second stage, the total of 435 samples was probabil-
ity proportional to size allocated to each selected ART
clinics. The participants were drawn from the PLHIV on
ART list using simple random sampling.Study tools
Questionnaires looking into client socio-demographics,
ART side effects as well as ART adherence information
was adapted from Adult AIDS Clinical Trial Group
(AACTG) which was translated into Nepali language,
pre-tested and modified [12]. ART adherence was recordedion
Western Central Eastern Total
4 9 4 25
2 5 1 12
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physician. In this study, for adherence assessment, last
one month self-reported adherence as mentioned in
National ART guideline, 2005 was adopted [5]. Save the
Children and National Center for AIDS and STD Control
(NCASC)/ Ministry of Health and Population (MoHP) of
Nepal were approached for evaluating the toolkit prior to
finalizing the same. The toolkit was first field tested on a
non-sample site, and after necessary adjustments, used for
the study. The project was coordinated by the Center for
Molecular Dynamics Nepal (CMDN), Kathmandu, Nepal.
Data collection
Field research was managed by the Project Manager
from CMDN and was jointly carried out by field re-
searcher as well as other local field personnel. For min-
imizing recall bias, the answers were double-confirmed
by asking the question more than once, allowing the
participants time to remember the events.
Operational definitions
Adherence
This is a self reported adherence to ART study in Nepal.
This is the simplest method, and most extensively used.
Patients are asked to report their own adherence – how-
ever, if used incorrectly it can be very inaccurate and will
usually result in an overestimation of the level of adher-
ence. Adherence was measured as per the mentioned
criteria in National ART Guideline of 2005 [5] which is
a) If less than three pills are missed during last one
month (30 days), the person is >95% adherent; b) if 3–
12 missed in the same period, 80-95% adherent; and c) if
12 pills missed, <80% adherent within one month of
period [4]. The importance of strict adherence to ART
cannot be overemphasized. Near perfect pill taking
(>95% - [6]) is required to achieve maximal viral sup-
pression – anything less than this leads rapidly to the
development of viral resistance and hence, too much
earlier treatment failure. WHO recommends at least
95% of adherence to ART to avoid the emergence of
resistant strains of HIV. Therefore, we categorized the
adherence level into two groups based on the above
criteria- Adherent:Group A : >95% adherence; Non-
Adherent:Groups B/C: <95% adherence.
Non adherence: Person missing more than three
doses of treatment is considered as non-adherent.
Infected duration:Time since client first found to be
infected (diagnosed) until the current time.
Thought of leaving medication: If clients felt like dis-
continuing ART.
Satisfaction from ART clinic: Perceived satisfaction
from the ART clinic was measured. Respondents’ satis-
faction with the health care providers was measured in
the survey by asking participants whether the way healthcare providers treated them was ‘excellent’, ‘good’, ‘fair’, or
‘bad’.
Data analysis
Data was entered and analyzed using the Statistical
Package for Social Sciences (SPSS) version 17. Univariate
and Bivariate analysis including chi-square tests, at 95%
confidence interval were carried out to analyze the data.
Possible errors and biases
Test subjects were clients that were selected from
among those that visited the treatment centre. Thus se-
lection bias against those not attending the treatment
centre is possible. In order to limit this bias home visits
to HIV positive persons on ART were carried out with
the help of the Community Based Health Care (CHBC)
workers.
Recall Bias may exist since the study is based on the
self –report of the client. In order to minimize this bias
the answers were reconfirmed by asking the question
more than once, providing the clients enough time to re-
member events. Where possible, any other supporting
information was also assessed to validate the answers.
Local language was used to avoid the potential bias of
misinterpretation of the questions.
Limitations
The study is limited by its cross-sectional design, i.e. as-
sociation cannot be interpreted as causal. The data man-
agement system was not electronic and thus some of the
data was missed.
Ethical approval
Ethical approval was obtained from the Ethical Review
Board of Nepal Health Research Council, 2010 (NHRC/
MoHP/Government of Nepal) prior to initiation of
study. Informed consent (written and verbal) was ob-
tained from the each participant prior to interviews and
data collection. Informed consent included information
related to purpose of the study, potential risks and bene-
fits of participating, procedures of maintaining confiden-
tiality, right to not to participate in this study, as well as
right to withdraw from interview at any point, were pro-
vided to the research subject.
Results
A total of four hundred and thirty five (435) patients
consented and participated in the study, out of which
data from 404 records were analyzed. Thirty one were
excluded for incompleteness. This represents a response
rate of 92.9% of the number of patients eligible for the
study. Among the thirty one patients who did not par-
ticipate in the study, eight declined on confidential
grounds, twelve did not give any reasons for the denying
Table 2 Socio demographic characteristics of participants




Third gender 2 0.5
Age
<35 years 179 44.4
≥35 years 225 55.6




Far western 115 28.5





















Can’t read and write 105 26.0
Read and write 63 15.6
Primary 75 18.6
Lower secondary 65 16.1
Secondary 66 16.3
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counts.
In terms of age group of the participants, less than 35
years old population accounted for 44.4% of the total
sample population. Males represented 52.0% of the study
population (Table 2), and only 0.5% Third Gender repre-
sentation. Among the clients interviewed, the majority
were married (83.5%). Forty two participants (10.3%)
were unmarried with a negligible number 13 (3.2%) that
were either divorced or separated. The majority of the
clients interviewed were of the ethnic Janajatis and
Chettris groups (as per Nepal Census nomenclature).
Tharu ethnicity accounted for the lowest representation
amongst all ethnicities. The main religion observed
amongst the clients was Hinduism (80.2%).
The majority of the ART clients (65.1%) were employed
in various sectors at the time of the interviews. The major-
ity of the ART clients were involved in the agricultural
sector. The remainder were either in government service,
business sector or worked as laborers. Their employment
was also their major source of income. Most of the ART
clients’ family income was less than NRs 5000 per month
(46.7%). Among participants, 127 (31.4%) reported a fam-
ily income between NRs 5000 and NRs 15000 (Table 2 de-
fines the equivalent USD). In terms of educational level,
105 (26.0%) participant couldn’t read and write. Of the re-
mainder (74.0%), almost equal number of participants had
different levels of education (Table 2).
Most (93%) of the clients did not drink alcohol at all.
Among the rest, there were both regular and rare
drinkers of alcohol. In terms of smoking as a habit, a
high percentage of participants said that they didn’t
smoke (79.6%); rest (20.4%) said those smoked at various
levels. Among the clients interviewed, 227 (56.2%) had
initiated the ART regimen in the last 1 to 4 years.
a. Status of last month ART adherence
Our study results have shown that the overall adherence
in the population (>95%) was 94.8% (n = 383). The ad-
herence as measured by the clients’ response to the
number of pills s/he missed in the last month of the pa-
tient’s regimen. Among the rest, 4.2% were 80–95 % ad-
herent while a small percentage (1.0%) showed less than
80% adherence (Figure 2).
b. Factors associated with adherence to ART
Statistical analysis was carried out on key indicators
playing a role in adherence amongst the adherent and
non-adherent population. Most of the variables tested
(for example: age, residence, ethnicity etc.) returned
non-significant results (Table 3). However three parame-
ters appeared to play a role in the adherence pattern of
the clients. The most significant (P < 0.05) findings that
affected ART adherence were a) level of education
Table 2 Socio demographic characteristics of participants
(Continued)
Others 40 9.9







Time to reach the ART clinic
<30 minutes 116 28.8
30 minutes-1 hour 108 26.8
1-2 hours 83 20.5











<1 year 82 20.3
1-4 years 227 56.1
≥5 years 95 23.5
Treatment duration
<1 year 161 39.9
1-4 years 227 56.2
≥5 years 16 4.0
#1 Nepalese Rupees (NRs) = 0.0113770 USD (as of 3rd March 2013
from http://www.xe.com/currencyconverter/).
**Drug use includes marijuana, injecting drugs or other habitual drugs.
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(P = 0.039) and c) the environment of the ART clinic that
the participants attended (P = 0.004).Wristwatch as a major facilitator
Among those that reported more than 95% adherence in
the last month (missed less than 3 pills), the leading fa-
cilitator in aiding timely consumption of the ARV medi-
cation was the common wristwatch worn by clients
(39%). Family and friends support appeared to play an
important role as well (38%) followed by radio (24%),timely availability of medicine (16%), and a prior collection
of medicine other than the scheduled visit to ART (16%).
Side effects as a major barrier
Among those clients reporting less than 95% adherence
in the last month (missed more than three pills), large
percentage 13(61.9%) mentioned that side effects were
the major reason for avoiding the treatment followed by
those stating being away from home 9 (42.9 %). Among
others, lack of ART knowledge, forgetfulness, road clo-
sures (strikes), death of the spouse, transportation prob-
lems and no access to medications were causes for non
adherence to ART (Table 4). Some of the side effects
claimed by the participants as a result of ART were: diz-
ziness (18.1%), headache (15.4%) and vomiting (13.8%).
Discussions
Adherence to ART regimen is by no means easy. Yet it
is a requirement to increase the longevity of PLHIV.
There are various difficulties a patient, already weakened
by the suppressed immune system would face in con-
tinuing the daily ART routine. This study has attempted
to outline the major difficulties faced by clients in devel-
oping country such as Nepal, as per information from
national guidelines, WHO, as well as other global HIV
bodies. These major areas were used as parameters to
assess the barriers to effective implementation of na-
tional ART guidelines at the community level.
Our study revealed an overall adherence (>95%) of
94.8%. This is higher than a previously conducted similar
study focusing on far western HIV population that
showed 84% [11]. Similar studies carried out elsewhere
have shown far lower >95% adherence results. It is
higher than the studies conducted in south Asian devel-
oping countries such as India, China and Thailand
[13-15]. In addition to those, adherence percentages of
43.2% in Kenya [16] and 62.5% in South Africa respect-
ively [17] have been reported. However, Lower adher-
ence at 48% has been reported in Ethiopia [18]. In that
regard, the adherence observed in our study can be con-
sidered relatively satisfactory as 95% are adherent to the
treatment. This can be attributed to increased awareness
of ART in the community and the benefits provided
therewith, mobilization of the CHBC, family support
and self-report of the ART adherence.
The simple wristwatch of clients appeared helpful in
supporting ART adherence in the clients. This watch
was instrumental in helping clients keep tab of time to
take their medication. Similar findings have been re-
ported in Ethiopia, Botswana, Tanzania and Uganda
[19-21] where memory aids have been used for reminder
regarding medication consumption. In a previous study
carried in Nepal to assess ART adherence, the watch was
used in a similar fashion [11].
Figure 2 Clients' self reported adherence of last month.
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ity of ART clients did not smoke, and they did not con-
sume alcohol. This may reflect a sense of responsibility
by the clients towards the treatment, and enhanced
awareness about the importance of ART and its relation
to HIV therapy through CHBC’s. Worldwide, alcohol
use has been documented as a prime barrier to treat-
ment adherence [22].
This indeed appears to be true for the good adherence
as the clients were very aware of the ART since most
have had pre- and post- ART counseling. This, and the
fact that in the majority of the cases they were satisfied
with the services provided at the ART sites (in terms of
waiting time, confidentiality, communication channels
among others) appears to have played a role in helping
the clients maintain adherence to their medication regi-
men. Consistent with other research of the influence of
patient-provider relationships on ART adherence [23,24],
this study found that the perceived quality of informa-
tion from health care providers was positively associated
with adherence.
Numerous studies have reported that experience of
side effects against prescribed medication tends lead to
non-adherence or cessation of intake [25-27]. In our
study, high percentage of non adherent clients (61.9%)
reported side effects as being the major cause for irregu-
lar adherence to ART. There are several reasons behind
this; one of the reason is that ART was started when the
CD4 count reached ≤ 200 cells/mm3 (as compared to
WHO recommendation of ≤ 350 cells/mm3) which
means treatment was started after the immune system
was already weakened, thus leading to heightened side
effects. Lower adherence is associated with experience of
medication side effects [28]
Although being away from home is a possible reason
for non-adherence as per literature [11], this does not
appear to be the case in our study. This could primarily
be due to the fact that social support groups are active
in Nepal and are usually placed near residential areas.This enables timely intervention by workers to reach the
client and provide advice on ART.
Our finding suggest that increase in education level
(including secondary, higher secondary and higher) was
not related to better adherence; lower level educational
status showed better adherence. This contradicts to the
finding of study conducted in Nigeria [29]. Participants
with a history of various drug habits (e. g. Marijuana,
injecting drug or other habitual drugs) have been linked
with lower adherence level [30,31].
The majority of the participants in our study that had
drug habits were unemployed, likely to be involved in
illicit drug related transactions as source of funds for
drug purchase. The positive environment of ART clinics
appears to be directly related to good adherence – a
finding similar to that found in a study from Africa [21].
This study did have certain field limitations in terms
of accessing information as data source. The main limi-
tations was that the pill count was not carried out while
interviewing the participants. This was difficult to carry
out as study sites were ART clinics where clients come
once a month (every ART clinic offers in an average
once month medicine) to refill medication. In most
cases, those clients do not bring their remaining pills, if
any. Further, the clients were unable to, in many in-
stances, reveal their CD4 counts at the start of ART
regimen. Further, this study relied on interviews with
ART clients, and as such was based on self-reporting.
Recall bias would always be possible in such instances.Conclusions
This study has identified some of the barriers to adher-
ence in a developing country setting, and in particular,
in a country with difficult geographical terrains and lim-
ited modes of transport. Distances between health care
settings and homes, as well as means to get between
those are some of the impediments identified by this
study, for ART adherence.
Table 3 Factors associated with adherence to ART
Variables Adherent (≥95%) Non Adherent (<95%) P-valuea
n = 383 % n = 21 %
Gender
Male 198 51.7 12 57.1 0.454
Female 183 47.8 9 42.9
Third gender 2 0.5 0 0.0
Age
<35 years 172 45 7 33.3 0.772
≥35 years 211 55 14 66.7
Residence (according to region)
Eastern 34 8.9 3 14.3 0.116
Central 107 27.9 10 47.6
Western 118 30.8 3 14.3
Far western 110 28.7 5 23.8
Mid western 14 3.7 0 0.0
Caste (ethnicity)
Brahmin 44 11.5 3 14.3 0.560
Chettry 112 29.2 5 23.8
Tharu 7 1.8 2 9.5
Dalit 63 16.5 3 14.3
Janjati 136 35.5 8 38.1
Others 21 5.5 0 0.0
Religion
Hindu 305 79.6 19 90.5 0.305
Buddhist 45 11.7 2 9.5
Muslim 10 2.6 0 0.0
Christian 20 5.3 0 0.0
Others 3 0.8 0 0.0
Marital status
Married 319 83.3 18 85.7 0.772
Un married 39 10.2 3 14.3
Divorced 2 0.5 0 0.0
Separated 11 2.9 0 0.0
Others 12 3.1 0 0.0
Education
Primary 67 17.5 8 38.1 0.018*
Lower secondary 60 15.7 5 23.8
Secondary 63 16.4 3 14.3
Higher secondary or higher 25 6.5 5 23.8
Can’t read and write 105 27.4 0 0.0
Read and write 63 16.4 0 0.0
Family income source
Agriculture 163 42.6 8 38.1 0.707
Service 88 23.0 8 38.1
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Table 3 Factors associated with adherence to ART (Continued)
Business 44 11.5 0 0.0
Labour 49 12.8 4 19.0
Others 39 10.2 1 4.8
Family total income (NRs) /month#
<5000 181 47.3 8 38.1 0.337
5000-9999 123 32.1 4 19.0
>10000 79 20.6 9 42.9
Employment status
Employed 249 65.0 14 66.7 0.419
Unemployed 134 35.0 7 33.3
Time to reach ART clinic
<30 minutes 107 27.9 9 42.9 0.936
30 minutes −1 hour 105 27.4 3 14.3
1-2 hours 80 20.9 3 14.3
>2 hours 91 23.8 6 28.6
Alcohol habit
Never 356 93.0 19 90.5
Once a month 10 2.6 0 0.0
1-4 times a week 10 0.3 2 9.5
Almost daily 4 1.0 0 0.0
Daily 3 0.8 0 0.0
Smoking habit
No 307 80.2 15 71.4 0.448
Yes 76 19.8 6 28.6
Drug uses** habit
No 358 94.2 16 76.2 0.039*
Yes 25 5.8 5 23.8
Disclosure of HIV status
Yes 305 79.6 13 61.9 0.180
No 78 20.4 8 38.1
Infected duration
<1 year 78 20.4 4 19.0 0.283
1-4 years 218 56.9 9 42.9
≥5 years 87 22.7 8 38.1
Treatment duration
<1 year 153 39.9 8 38.1 0.480
1-4 years 216 56.4 11 52.4
≥5 years 14 3.7 2 9.5
Thought of leaving medication
No 341 89.0 16 76.2 0.180
Yes 42 11.0 5 23.8
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Environment of ART clinic
Very good 220 57.4 11 52.4 0.004*
Good 62 16.2 3 14.3
Satisfactory 1 0.3 2 9.5
Not good 100 26.1 5 23.8
Medium of travel mode
Walking 48 12.5 2 9.5 0.898
Bus 258 67.4 15 71.4
Own vehicle 21 5.5 0 0.0
Rickshaw or Bicycle 49 12.8 4 19.0
Others 7 1.8 0 0.0
Satisfaction from ART clinic
Yes 366 95.6 21 100
No 17 4.4 0 0.0
#1 Nepalese Rupees (NRs) = 0.0113770 USD (as of 3rd March 2013 from http://www.xe.com/currencyconverter/).
*Significant P values on 95% CI.
**drug use includes marijuana, injecting drug or other habitual drugs.
aP values were calculated from chi square test.
NRs: Nepalese Rupees.
ART:Anti Retroviral Therapy.
Bam et al. BMC Health Services Research  (2015) 15:188 Page 10 of 11The most significant finding was that education, drug
use habits and the environment of ART clinics affected
adherence to ART. Results from this study have clearly
demonstrated that having a higher level of education
was more likely to result in increased adherence as com-
pared to basic education. Furthermore, the drug uses
habit group appeared to have more difficulty maintain-
ing adherence as compared to habit of none drug users.
This finding clearly identifies the need to pay special at-
tention to this key affected population regarding ART
medication in Nepal. Also, having a positive opinion
about the healthcare centers that provide medication as
well as counseling appeared to positively influence ART
adherence and should thus be promoted.Table 4 Reason for non adherence to ART(n = 21)*
Reasons n (% )
Avoid side effects 13(61.9)
Away from home 9(42.9)
Lack of ART knowledge 9(42.9)
Afraid of taking medication 9(42.9)
Forgot to take medication 9(42.9)
No access to watch 7(33.3)
Road closures (strikes) 7(33.3)
Death of husband/spouse 7(33.3)
Transportation problems 7(33.3)
No access to medication 7(33.3)
*multiple response analysis was allowed.This type of study, if carried out at a national level
would be expected to provide a more comprehensive in-
formation on national ART adherence and behavioral
data. This study can also have a role in helping inter-
national community understand the difficulties of ART
implementation in developing countries. Together, better
plans and policies can be formulated to make ART ad-
herence 100% all over the country and in other develop-
ing countries as well. Already, the adherence rate in
Nepal far exceeds those observed in other developing
countries in Africa. However, there is always room for
improvement, and opportunities to save more lives.
While this study identified major gaps in ART adher-
ence by clients, there are still areas for further studies to
try to understand remaining gaps. A requirement for pill
count at ART clinics could be an important mechanism
to support adherence to the regimen. There also is a
need for ART clinics to be decentralized- instead of
current district headquarters implementing the treat-
ment, health posts and sub health posts across the coun-
try should also be utilized to provide such services.
There is also a need to implement cross-country coord-
ination mechanisms between Nepal and neighboring
India where Nepali migrant workers travel for work,
whereby Nepali ART clients can access ART services at a
place of employment in India.
This study also shows that there is a need to increase
care homes, expand CHBC worker access to clients, and
increase ART clinics in all 75 districts of Nepal in order
to improve access to medication thereby facilitating
adherence to ART. Further, improving currently
Bam et al. BMC Health Services Research  (2015) 15:188 Page 11 of 11implemented governmental nutritional support for ART
clients, improving healthcare facilities so that the clients
are more likely to visit and adhere to ART regimen, are
some of the recommendations from the study findings, to-
wards improving adherence in Nepal by clients on ART.
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